Latest 10-K annual reports
NASDAQ
Future FinTech Group Inc. details its financial performance for the year ended December 31, 2024, highlighting a shift in business focus and addressing ongoing legal and regulatory hurdles.
OID
Transportation and Logistics Systems, Inc. reports a net loss of $3.82 million for 2024 and expresses substantial doubt about its ability to continue as a going concern in its latest 10-K filing.
Beeline Holdings, formerly Eastside Distilling, reports its 10-K filing, highlighting a year of strategic transformation marked by the acquisition of Beeline Financial, the sale of its craft business, and a shift in focus towards fintech mortgage lending and spirits distribution.
NASDAQ
Algorhythm Holdings, an AI technology and consumer electronics holding company, reports a net loss for 2024, impacted by non-cash charges and strategic business developments.
10-K: Wenyuan Group Corp. Reports Increased Revenue in 2024, Shifts Focus to Cultural and Health Products
Wenyuan Group Corp. reports a significant increase in revenue for 2024 driven by cultural and health product sales, while discontinuing its aquaculture business.
OTC.Pink
Forge Innovation Development Corp.'s 2024 10-K filing reveals a revenue increase driven by the Legend LP acquisition, but also highlights substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flow.
NASDAQ
ZW Data Action Technologies Inc. reports a decrease in revenue for fiscal year 2024 due to a strategic repositioning, focusing on higher-margin digital advertising opportunities.
ONAR Holding Corporation's 10-K filing reveals a strategic focus on marketing technology amid financial concerns and internal control weaknesses.
OID
Charging Robotics Inc. files its annual report on Form 10-K, detailing its financial performance and strategic focus on wireless charging systems for electric vehicles, particularly in robotic parking systems.
AMEX
Milestone Scientific's 2024 10-K filing reveals a decrease in revenue, continued operating losses, and efforts to secure additional funding while expanding its medical product line and distribution.
NASDAQ
OLB Group's 2024 annual report reveals a substantial revenue decrease and a net loss, highlighting challenges in its core business segments and ongoing efforts to spin off its Bitcoin mining operations.
OTC.Pink
10-K: Mosaic ImmunoEngineering Faces Going Concern Uncertainty Amidst Pursuit of Oncotelic Acquisition
Mosaic ImmunoEngineering's 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite efforts to acquire new technologies from Oncotelic Therapeutics.
NASDAQ
10-K/A: Jaguar Health Files Amendment to 10-K, Discloses Executive and Director Compensation Details
Jaguar Health amends its annual report to include previously omitted information regarding directors, executive officers, and corporate governance.
NASDAQ
Maywood Acquisition Corp.'s Form 10-K filing describes the terms and structure of its securities, including Class A and Class B ordinary shares, rights, and units, as well as related agreements and potential risks.
OTC.Pink
World Health Energy Holdings reports a net loss of $4.9 million for 2024, alongside strategic acquisitions and ongoing concerns about its ability to continue as a going concern.
Alpha Modus Holdings, Inc. reports its 2024 financial results, marking the completion of its business combination and outlining its strategy for patent licensing and enforcement.
OQB
CFN Enterprises Inc.'s 2024 10-K filing reveals a significant revenue increase driven by the Ranco acquisition, but the company still faces substantial financial challenges and a going concern warning.
NASDAQ
Patriot National Bancorp faced a challenging 2024, reporting a substantial net loss and outlining plans for a $57.75 million private placement to bolster its financial position.
OTC.Pink
FLCX
Flooidcx CORP10-K: Quantum Energy Corp. Reports $6.5 Million Revenue for Fiscal Year 2023, Eyes Expansion in 2025
Quantum Energy Corp. reports a significant revenue increase to $6.5 million for 2023, driven by licensed distributorship sales, and outlines plans for expansion and Direct Energy System installations in 2025.
NASDAQ
SOBR
Sobr Safe, INCSOBR Safe, Inc.'s 10-K filing reveals a net loss reduction, strategic developments including a reverse stock split and private placement, and continued focus on commercializing its alcohol monitoring technology.
OID
Regenerative Medical Technology Group's annual report highlights a 70.44% revenue increase in 2024 and details strategic initiatives for continued expansion in 2025.
NASDAQ
ALOT
Astronova, INCAstroNova's fiscal year 2025 results reveal a net loss driven by a significant goodwill impairment charge related to the MTEX acquisition, despite a slight increase in overall revenue.
OTC.Pink
First Choice Healthcare Solutions is pivoting from its historical orthopedic business to a national chain of primary care and wellness clinics, while addressing financial losses and legal proceedings.
Integrated Wellness Acquisition Corp's 10-K filing reveals ongoing efforts to complete a business combination with Btab Ecommerce Group, challenges with NYSE delisting, and financial uncertainties impacting its ability to continue as a going concern.
AMEX
Air Industries Group saw a revenue increase and backlog growth in 2024, but still reported a net loss, according to its latest 10-K filing.
NASDAQ
TSSI
Tss, INCTSS, Inc. announces a significant increase in revenue and a return to profitability in its 2024 10-K filing, driven by growth in AI-enabled rack integration and procurement services.
10-K: Shorepower Technologies Reports Increased Revenue but Continues to Face Losses in Fiscal Year 2024
Shorepower Technologies saw a significant revenue increase in 2024, but net losses persist as the company focuses on expanding its electric vehicle charging infrastructure.
NASDAQ
Princeton Bancorp files an amendment to its annual report on Form 10-K to include previously omitted exhibits and to amend employment agreements with key executives.
OQB
Vycor Medical's 2024 10-K filing reveals a revenue increase driven by US sales, but also highlights concerns about the company's ability to continue as a going concern due to accumulated losses and working capital deficiency.
OTC.Pink
Sigyn Therapeutics' 2024 annual report details the company's ongoing development of medical devices for cancer and infectious disease, including its lead candidate, Sigyn TherapyTM, and its efforts to secure additional capital.